Ian Postlethwaite

Biography

Ian Postlethwaite, is Chief Financial Officer and Board of Directors member of the NetScientific Plc, and Deputy Chairman of Shoreham Port. He joined NetScientific in June 2016. NetScientific is a transatlantic healthcare IP commercialisation Group focused on improving the health and wellbeing of people with chronic diseases. He was previously Finance Director and a member of the Board of Directors for 14 years of Allergy Therapeutics Plc. He joined Allergy in April 2002, whilst it was private company, initially performing a financial turnaround and then listing it two years later in 2004 on the AIM of the London Stock Exchange. Revenue increased from £12m to £49m over his tenure and he raised £107m through equity issues and €40m through debt finance to fund over 15 clinical studies, including 3 phase III studies. Prior to this he worked for Ellerman Investments (1997 – 2002), a UK private equity house, undertaking the roles of Chief Executive Officer with AFS, which was one of the largest independent finance houses in the UK, raising over £400m in debt finance, and Finance Director of a number of their successful start-up technology companies. Previously he held senior finance positions with Ericsson and Philips Electronics.

Research Interest

chronic diseases